Expired activity
Please go to the PowerPak
homepage and select a course.
Flu Forum: What to Expect in 2021-2022
This continuing pharmacy educational activity is provided by Vindico Medical Education and supported by an educational grant from Genentech, a member of the Roche Group.
RELEASE DATE
October 29, 2021
EXPIRATION DATE
October 28, 2022
Target Audience
The intended audience for this activity is pharmacists and other health care professionals involved in the management of patients with influenza.
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
- Differentiate influenza from other respiratory conditions by utilizing appropriate diagnostic tools that can detect the disease early in its course.
- Select antiviral treatment based upon efficacy and safety in patients who are at normal or high risk for complications.
- Incorporate the use of antiviral prophylaxis when appropriate to reduce the potential for influenza infection.
Activity Co-Chairs
Paul G. Auwaerter, MD, MBA, FIDSA
Sherrilyn and Ken Fisher Professor of Medicine
Clinical Director, Division of Infectious Diseases
Director, Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, MD
Margot Savoy, MD, MPH, FAAFP, FABC, CPE, CMQ, FAAPL
Associate Professor, Family & Community Medicine and Center for Urban Bioethics
Lewis Katz School of Medicine at Temple University & Temple University Health System
Philadelphia, PA
Overview
Influenza places a substantial burden on the health of people in the United States each year. Although influenza cases were abnormally low in 2020-2021 during the COVID-19 pandemic, numbers are expected to rebound as we enter the upcoming respiratory virus season. Clinicians who evaluate and treat these patients must keep apprised of new information regarding timely diagnosis and treatment of influenza in order to minimize patient morbidity and mortality. Education is required to facilitate early treatment and optimal use of antivirals. In this CME/CNE/CPE meeting series, Flu Forum: What to Expect in 2021-2022, experts will explore strategies for early diagnosis of influenza using evidence-based guidelines and discuss treatment selection based on patient risk factors and the efficacy and safety of available antiviral therapies. Recommendations and options for post-exposure prophylaxis of influenza will also be discussed. Clinical cases will be presented to highlight the key educational objectives and address challenges in influenza diagnosis and management in the era of COVID-19.
Accreditation
Vindico Medical Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
Credit Designation
This program is acceptable for 1.00 contact hours of ACPE Continuing Education Credit. The ACPE Universal Program Number 0482-0000-21-027-H01-P. This is a knowledge-based activity, and there is no fee to attend.
This enduring material is approved for 1 year from the date of original release, October 29, 2021, to October 28, 2022.
How to Participate in This Activity and Obtain CME Credit
To participate in this CE activity, you must read the objectives, answer the pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 out of 4 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue a CPE Statement of Credit. Vindico will report pharmacist learners to CPE monitor within 30 days of completion of the activity.
Disclosures
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, faculty, and reviewers involved in the development of accredited content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control. Relationship information appears below.
Activity Co-Chairs report the following relationships
Paul G. Auwaerter, MD, MBA, FIDSA
Individual Stocks & Stock Option: Johnson & Johnson
Margot Savoy, MD, MPH, FAAFP, FABC, CPE, CMQ, FAAPL
Board of Directors: AAFP
CME Advisory Committee: US Government
Honorarium: Merck Manual
Planners & Reviewers report the following relationships
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Jennifer Frederick, PharmD, BCPS
No relevant financial relationships to disclose.
Barbara A. Niedz, PhD, RN, CPHQ
Consultant: Beckton Dickinson
Chad Rittle, DNP, MPH, RN, FAAOHN
No relevant financial relationships to disclose.
Vindico Medical Education staff have no relevant financial relationships to disclose.
Signed Disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2021 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at CME@VindicoCME.com
